Loading chat...
CA AR110
Resolution
Status
Passed
5/29/2018
Primary Sponsor
Kevin Mullin
Click for details
AI Summary
- Proclaims the week of May 21, 2018, as Tardive Dyskinesia Awareness Week in California
- Recognizes that Tardive Dyskinesia (TD) is a movement disorder caused by dopamine receptor blocking agents used to treat serious mental illness and gastrointestinal disorders, characterized by involuntary movements of the face, trunk, and extremities
- Notes that TD can develop months or years after starting these medications, is often permanent, and affects an estimated 60,000 Californians, with a 30-50 percent risk of developing after prolonged exposure
- Highlights that two new FDA-approved treatments for TD were recently developed and recommends regular screening using American Psychiatric Association rating scales for patients taking these medications
- Calls attention to the social isolation and challenges faced by TD patients and their caregivers due to the disease's visible symptoms
Legislative Description
Relative to Tardive Dyskinesia Awareness Week.
Last Action
Read. Adopted. (Page 5400.).
5/29/2018
Committee Referrals
Rules5/21/2018
Full Bill Text
No bill text available